Source: International Congress 2019 – Clinical challenges in respiratory infection
Disease area: Respiratory critical care, Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
B. Seeliger (Hannover, Germany), K. Stahl (Hannover, Germany), M. Busch (Hannover, Germany), O. Wiesner (Hannover, Germany), T. Welte (Hannover, Germany), M. Hoeper (Hannover, Germany), M. Eder (Hannover, Germany), A. Heim (Hannover, Germany), S. David (Hannover, Germany). Immunosuppression is associated with lower morbidity and mortality in the 2017/2018 influenza epidemic. 4561

Member's Comments

No comment yet.

Related content which might interest you: Predictors of in-hospital mortality in influenza infection. Source: International Congress 2019 – Prognosis in bacterial and viral pneumonia Year: 2019 Underestimation of COVID-19 mortality during the pandemic Source: ERJ Open Res, 7 (1) 00766-2020; 10.1183/23120541.00766-2020 Year: 2021 Impact of bacterial co-infection with COVID-19 on morbidity and mortality Source: Virtual Congress 2021 – COVID - 19 epidemiology Year: 2021 Obesity and risk of pneumonia in patients with influenza Source: Eur Respir J 2011; 37: 1298 Year: 2011 Statin use is associated with reduced mortality after respiratory viral infection Source: ERJ Open Res, 7 (1) 00365-2020; 10.1183/23120541.00365-2020 Year: 2021 Varicella-Zoster virus pneumonia in an adult population. Has the mortality decreased? Source: Annual Congress 2010 - Unusual pathogens in respiratory infections Year: 2010 Fenofibrate is associated with higher risk of mortality in patients with tuberculosis infection Source: International Congress 2019 – Tuberculosis: from diagnosis to complications Year: 2019 Influenza and pneumoccocal vaccination protect against all cause mortality in COPD Source: Annual Congress 2008 - Community-acquired pneumonia: prognosis, complications and prevention Year: 2008 Early childhood infections with rotavirus and norovirus are associated with risk of developing asthma Source: Annual Congress 2011 - Risk and detection of childhood asthma and allergy Year: 2011 Societal perspective and challenges of influenza and pneumococcal vaccination in patients at risk of respiratory complications Source: Annual Congress 2008 - Why vaccinate patients with chronic respiratory conditions? Today and tomorrow's perspectives Year: 2008 Influenza vaccination is associated with reduced severity of community-acquired pneumonia Source: Eur Respir J 2011; 37: 147-153 Year: 2011 Potential causes of increased long-term mortality after pneumonia Source: Eur Respir J 2011; 37: 1306-1307 Year: 2011 The problem of early mortality in pneumococcal pneumonia: a study of risk factors Source: Eur Respir J 2015; 46: 561-564 Year: 2015 Bacteremic pneumococcal pneumonia is associated with an increased rate of cardiovascular events Source: International Congress 2019 – Pneumonia in 2019: antimicrobial resistance, cardiovascular complications and diagnosis Year: 2019 Inflammatory responses predict long-term mortality risk in community-acquired pneumonia Source: Eur Respir J 2011; 37: 1439-1446 Year: 2011 Reducing childhood respiratory morbidity and mortality in low and middle income countries: a current challenge Source: Eur Respir J, 54 (1) 1900987; 10.1183/13993003.00987-2019 Year: 2019 Breast feeding and infant mortality from acute respiratory infections: estimation of preventable deaths Source: Annual Congress 2008 - Paediatric respiratory epidemiology II: air pollution studies and infectious disease epidemiology Year: 2008 Factors affecting vaccination rates against influenza in adults with asthma Source: Virtual Congress 2020 – Epidemiology and understanding of airways diseases in primary care Year: 2020